Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Lymphoid 1Genitourinary 1Gastrointestinal 1CNS 1

Conditions

Breast Neoplasms 29Neoplasms 12Lung Neoplasms 11Endometrial Neoplasms 11Stomach Neoplasms 10Lymphatic Metastasis 7Head and Neck Neoplasms 7Melanoma 6Esophageal Neoplasms 6Carcinoma, Hepatocellular 6Uterine Cervical Neoplasms 5Colonic Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Rectal Neoplasms 4Ovarian Neoplasms 4Sarcoma 3Prostatic Neoplasms 3Lymphedema 3Colorectal Neoplasms 3Brain Neoplasms 3Vulvar Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Solitary Pulmonary Nodule 2Sarcoma, Ewing 2Rhabdomyosarcoma 2Peritoneal Neoplasms 2Osteosarcoma 2Multiple Pulmonary Nodules 2Margins of Excision 2Giant Cell Tumor of Bone 2

Interventions

Cyclophosphamide 444Rituximab 401Etoposide 224Vincristine 215Doxorubicin 201Filgrastim 200Prednisone 176Cytarabine 159Radiotherapy 152fludarabine phosphate 147Methotrexate 137Peripheral Blood Stem Cell Transplantation 129Melphalan 127fludarabine 115Busulfan 99Dexamethasone 93Tacrolimus 75Carmustine 74Granulocyte Colony-Stimulating Factor 73Mycophenolic Acid 71Gemcitabine 66Bortezomib 65Antilymphocyte Serum 65Whole-Body Irradiation 62Cyclosporine 62Bendamustine Hydrochloride 62Lenalidomide 60Ifosfamide 58sargramostim 51Methylprednisolone 49

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Lymphoma × Indocyanine Green × Clear all
NCT04084067 2026-04-30

Indocyanine Green (ICG) Guided Tumor Resection

St. Jude Children's Research Hospital

Phase 1 Recruiting
230 enrolled
CNSGastrointestinalGenitourinaryLymphoidSarcoma

Carcinoma, Renal Cell, Carcinoma, Hepatocellular, Lymphoma, Neoplasms, Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡